GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endexx Corp (OTCPK:EDXC) » Definitions » ROCE %

Endexx (Endexx) ROCE % : 0.00% (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Endexx ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Endexx's annualized ROCE % for the quarter that ended in Jun. 2023 was 0.00%.


Endexx ROCE % Historical Data

The historical data trend for Endexx's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endexx ROCE % Chart

Endexx Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Endexx Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Endexx ROCE % Calculation

Endexx's annualized ROCE % for the fiscal year that ended in Sep. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Sep. 2022 )  (A: Sep. 2021 )(A: Sep. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Sep. 2022 )  (A: Sep. 2021 )(A: Sep. 2022 )
=-3.903/( ( (1.76 - 11.499) + (13.278 - 18.384) )/ 2 )
=-3.903/( (-9.739+-5.106)/ 2 )
=-3.903/-7.4225
=52.58 %

Endexx's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2023 )  (Q: Mar. 2023 )(Q: Jun. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2023 )  (Q: Mar. 2023 )(Q: Jun. 2023 )
=-6.78/( ( (12.883 - 20.371) + (12.163 - 25.326) )/ 2 )
=-6.78/( ( -7.488 + -13.163 )/ 2 )
=-6.78/-10.3255
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Endexx  (OTCPK:EDXC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Endexx ROCE % Related Terms

Thank you for viewing the detailed overview of Endexx's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Endexx (Endexx) Business Description

Traded in Other Exchanges
N/A
Address
38246 North Hazelwood Circle, Cave Creek, AZ, USA, 85331
Endexx Corporation formerly known as CBD Unlimited Inc develops CBD-based products. It sells high-end, full-spectrum CBD oils, topicals, and pet products, to support the therapeutic relief of pain and inflammation for humans and pets, through its e-commerce site and other online and in-store retailers. Its product category includes Blesswell, Heritage Line, Topicals, Ingestibles, Maggie's Line, X-Line and Pets.